The present disclosure provides methods of treating brain injuries or conditions, or symptoms of brain injuries or conditions, including intranasal administration of a therapeutically effective amount of a taxane. The intranasally administered taxane can bypass the blood-brain barrier (BBB) via the olfactory epithelium and thereby provide therapeutic effect to a subject.